Seres Therapeutics (1S90.STU) Q2 2026 Earnings

5MayConfirmed
Q2 2026
-1.78
-1.72
-1.66
-1.6

Details

Expected EPS
-1.6043732
Actual EPS
-1.7750512
Surprise EPS
-0.17
Surprise Percent
+10.64%

Description

Seres Therapeutics (1S90.STU) has reported earnings of -1.7750512 per share for Q2 2026.

0 Comments

Share your thoughts